Background/Aims: There are important sex-related differences in the prevalence of obesity, type 2 diabetes mellitus and cardiovascular disease. Indeed, premenopausal women have a lower prevalence of these conditions relative to age-matched men. Estrogen participates in the modulation of insulin sensitivity, energy balance, and body composition. In this paper, we investigated the impact of estrogen signaling through estrogen receptor ␣ (ER ␣ ) on systemic insulin sensitivity and insulin signaling in skeletal muscle. Methods: In 14-and 30-week-old female ER ␣ knockout (ER ␣ KO) mice and age-matched controls, we assessed insulin sensitivity by a euglycemic-hyperinsulinemic clamp and intraperitoneal glucose tolerance testing. Blood pressure was evaluated by tail cuff and telemetry. We studied ex vivo insulin-stimulated glucose uptake in skeletal muscle tissue, as well as insulin metabolic signaling molecule phosphorylation by immunoblotting and oxidative stress by immunostaining for 3-nitrotyrosine. Results: Body weight was higher in ER ␣ KO mice at 14 and 30 weeks of age. At 30 weeks, intraperitoneal glucose tolerance testing and clamp results demonstrated impaired systemic insulin sensitivity in ER ␣ KO mice. Insulin-stimulated glucose uptake in soleus was lower in ER ␣ KO mice at both ages. The insulin receptor substrate 1/phosphatidylinositol 3-kinase association and the activa- tion of protein kinase B were decreased in ER ␣ KO mice, whereas immunostaining for 3-nitrotyrosine was increased. Conclusions: Our data demonstrate a critical age-dependent role for estrogen signaling through ER ␣ on whole-body insulin sensitivity and insulin metabolic signaling in skeletal muscle tissue. These findings have potential translational implications for the prevention and management of type 2 diabetes mellitus and cardiovascular disease in women, who are at increased risk for these conditions.